Effect of SGLT2 inhibitors on serum magnesium level in diabetic patients with hypomagnesemia and chronic kidney disease
Background: Hypomagnesemia is a frequent electrolyte abnormality observed among individuals with diabetes, particularly those with chronic kidney disease (CKD). Sodium-glucose cotransporter 2 inhibitors (SGLT2) have revealed potential benefits in modifying electrolyte balance, but their impact on se...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Armed Forces College of Medicine
2025-10-01
|
| Edice: | Arcades of Medicine |
| Témata: | |
| On-line přístup: | https://arcmed.journals.ekb.eg/article_457661.html |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|